Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
US Patent 10766892 GLS1 inhibitors for treating disease
Overview
Structured Data
Issues
Contributors
Activity
All edits
Edits on 17 Apr, 2024
"update inverses"
Golden AI
edited on 17 Apr, 2024
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent Citations Received
US Patent 11958849 GLS1 inhibitors for treating disease
0
Edits on 18 Oct, 2023
"update inverses"
Golden AI
edited on 18 Oct, 2023
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent Citations Received
US Patent 11786500 Glutaminase inhibitor therapy
Edits on 2 Aug, 2023
"update inverses"
Golden AI
edited on 2 Aug, 2023
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent Citations Received
US Patent 11713313 GLS1 inhibitors for treating disease
0
Edits on 20 May, 2023
"Remove website redirecting to Patent Public Search front page"
Golden AI
edited on 20 May, 2023
Edits made to:
Infobox
(
-1
properties)
Infobox
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=10766892
0
0
Edits on 28 Apr, 2023
"update citations for inverse infoboxes"
Golden AI
edited on 28 Apr, 2023
Infobox
Patent Citations
US Patent 10344025 GLS1 inhibitors for treating disease
0
Edits on 24 Apr, 2023
"update citations for inverse infoboxes"
Golden AI
edited on 24 Apr, 2023
Infobox
Patent Citations
US Patent 10125128 GLS1 inhibitors for treating disease
0
"Entity importer update"
Golden AI
edited on 24 Apr, 2023
Infobox
Is a
Patent
0
Patent Jurisdiction
United States Patent and Trademark Office
0
Patent Number
10766892
0
Date of Patent
September 8, 2020
0
Patent Application Number
16412050
0
Date Filed
May 14, 2019
0
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=10766892
0
Patent Citations
US Patent 10125128 GLS1 inhibitors for treating disease
0
US Patent 10344025 GLS1 inhibitors for treating disease
0
Patent Citations Received
US Patent 10899740 Salt forms and polymorphs of (R)-1-(4-(6-(2-(4-(3,3-difluorocyclobutoxy)-6-methylpyridin-2-yl)acetamido)pyridazin-3-yl)-2-fluorobutyl)-N-methyl-1H-1,2,3-triazole-4-carboxamide
0
US Patent 11045443 Glutaminase inhibitor therapy
0
US Patent 11370786 GLS1 inhibitors for treating disease
0
US Patent 11603365 Salt forms and polymorphs of (r)-1-(4-(6-(2-(4-(3,3-difluorocyclobutoxy)-6-methylpyridin-2-yl)acetamido) pyridazin-3-yl)-2-fluorobutyl)-n-methyl-1H-1,2,3-triazole-4-carboxamide
0
Patent Primary Examiner
John M Mauro
0
Edits on 27 Mar, 2023
"update citations for inverse infoboxes"
Golden AI
edited on 27 Mar, 2023
Infobox
Patent Citations Received
US Patent 10899740 Salt forms and polymorphs of (R)-1-(4-(6-(2-(4-(3,3-difluorocyclobutoxy)-6-methylpyridin-2-yl)acetamido)pyridazin-3-yl)-2-fluorobutyl)-N-methyl-1H-1,2,3-triazole-4-carboxamide
0
Edits on 27 Mar, 2023
"update citations for inverse infoboxes"
Golden AI
edited on 27 Mar, 2023
Infobox
Patent Citations Received
US Patent 11603365 Salt forms and polymorphs of (r)-1-(4-(6-(2-(4-(3,3-difluorocyclobutoxy)-6-methylpyridin-2-yl)acetamido) pyridazin-3-yl)-2-fluorobutyl)-n-methyl-1H-1,2,3-triazole-4-carboxamide
0
Edits on 21 Mar, 2023
"update citations for inverse infoboxes"
Golden AI
edited on 21 Mar, 2023
Infobox
Patent Citations Received
US Patent 11370786 GLS1 inhibitors for treating disease
0
Edits on 15 Mar, 2023
"update inverses"
Golden AI
edited on 15 Mar, 2023
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent Citations Received
US Patent 11603365 Salt forms and polymorphs of (r)-1-(4-(6-(2-(4-(3,3-difluorocyclobutoxy)-6-methylpyridin-2-yl)acetamido) pyridazin-3-yl)-2-fluorobutyl)-n-methyl-1H-1,2,3-triazole-4-carboxamide
0
Edits on 26 Sep, 2022
"update citations for inverse infoboxes"
Golden AI
edited on 26 Sep, 2022
Infobox
Patent Citations Received
US Patent 10899740 Salt forms and polymorphs of (R)-1-(4-(6-(2-(4-(3,3-difluorocyclobutoxy)-6-methylpyridin-2-yl)acetamido)pyridazin-3-yl)-2-fluorobutyl)-N-methyl-1H-1,2,3-triazole-4-carboxamide
0
Edits on 25 Sep, 2022
"Entity importer update"
Golden AI
edited on 25 Sep, 2022
Infobox
Is a
Patent
0
Patent Jurisdiction
United States Patent and Trademark Office
0
Patent Number
10766892
0
Date of Patent
September 8, 2020
0
Patent Application Number
16412050
0
Date Filed
May 14, 2019
0
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=10766892
0
Patent Citations
US Patent 10125128 GLS1 inhibitors for treating disease
0
US Patent 10344025 GLS1 inhibitors for treating disease
0
Patent Citations Received
US Patent 10899740 Salt forms and polymorphs of (R)-1-(4-(6-(2-(4-(3,3-difluorocyclobutoxy)-6-methylpyridin-2-yl)acetamido)pyridazin-3-yl)-2-fluorobutyl)-N-methyl-1H-1,2,3-triazole-4-carboxamide
0
US Patent 11045443 Glutaminase inhibitor therapy
0
US Patent 11370786 GLS1 inhibitors for treating disease
0
Patent Primary Examiner
John M Mauro
0
"update citations for inverse infoboxes"
Golden AI
edited on 25 Sep, 2022
Infobox
Patent Citations
US Patent 10125128 GLS1 inhibitors for treating disease
0
Edits on 29 Jun, 2022
"update inverses"
Golden AI
edited on 29 Jun, 2022
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent citations received
US Patent 11370786 GLS1 inhibitors for treating disease
Edits on 8 Jun, 2022
"Entity importer update"
Golden AI
edited on 8 Jun, 2022
Edits made to:
Infobox
(
+1
properties)
Infobox
Website URL
https://pdfpiw.uspto.gov/.piw?Docid=10766892
Edits on 12 Feb, 2022
"update inverses"
Golden AI
edited on 12 Feb, 2022
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent citations received
US Patent 11045443 Glutaminase inhibitor therapy
Edits on 9 Feb, 2022
"update inverses"
Golden AI
edited on 9 Feb, 2022
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent citations received
US Patent 10899740 Salt forms and polymorphs of (R)-1-(4-(6-(2-(4-(3,3-difluorocyclobutoxy)-6-methylpyridin-2-yl)acetamido)pyridazin-3-yl)-2-fluorobutyl)-N-methyl-1H-1,2,3-triazole-4-carboxamide
Edits on 6 Feb, 2022
"Created via: Entity Importer"
Golden AI
created this topic on 6 Feb, 2022
Edits made to:
Infobox
(
+9
properties)
US Patent 10766892 GLS1 inhibitors for treating disease
Infobox
Is a
Patent
Patent jurisdiction
United States Patent and Trademark Office
Patent number
10766892
Date of patent
September 8, 2020
Patent application number
16412050
Date Filed
May 14, 2019
Patent citations
US Patent 10125128 GLS1 inhibitors for treating disease
US Patent 10344025 GLS1 inhibitors for treating disease
Patent primary examiner
John M Mauro
Find more entities like US Patent 10766892 GLS1 inhibitors for treating disease
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
SUBSCRIBE